Prin Pharmaceutical's gabexate mesilate injection has obtained market approval in Belarus.

On June 5th, Prilly Pharmaceuticals announced that the company recently received market approval for gadopentetate injectable solution from the Belarusian drug regulatory authority, with two approved specifications: 1mmol/ml, 7.5ml/bottle and 15ml/bottle. This marks Prilly Pharmaceuticals' qualification to sell gadopentetate injectable solution in Belarus.